HCV NS4 Protein (AA 1916-1947)

Produktnummer ABIN2129661

Produktdetails

Target: HCV NS4 (Hepatitis C Virus NS4 (HCV NS4))

Protein-Typ: Recombinant

Proteineigenschaft: AA 1916-1947

Spezies: Hepatitis C Virus (HCV)

Quelle: Escherichia coli (E. coli)

Applikation: Western Blotting (WB), ELISA

Produktmerkmale: Hepatitis C Virus NS4 (1916-1947 a.a.) recombinant protein
Expression System: E.coli

Aufreinigung: Proprietary chromatographic technique

Reinheit: > 95 % pure

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 1.5 M urea, with 25 mM Tris-HCl, pH -8, 0.2 % Triton-X and 52 % glycerol.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: RT/-20 °C

Antigendetails

Target: HCV NS4 (Hepatitis C Virus NS4 (HCV NS4))

Andere Bezeichnung: Hepatitis C Virus NS4 (HCV NS4 Produkte)

Substanzklasse: Viral Protein

Hintergrund: HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: HCV Recombinant protein, Hep C protein, HCV protein, Hepatitis C protein, HCV NS4 protein

Molekulargewicht: 30 kDa